Industry and FDA may further enhance communications during the application review and earlier phases as part of the sixth iteration of the Prescription Drug User Fee Act (PDUFA).
With the reauthorization talks for PDUFA VI nearing completion, draft commitment letter language is now on the table for various pre-market topics,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?